BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8180230)

  • 1. Mapping of DNA alkylation sites induced by adozelesin and bizelesin in human cells by ligation-mediated polymerase chain reaction.
    Lee CS; Pfeifer GP; Gibson NW
    Biochemistry; 1994 May; 33(19):6024-30. PubMed ID: 8180230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-specific DNA damage by AT-specific DNA-reactive drugs is predicted by drug binding specificity.
    Woynarowski JM; Napier C; Trevino AV; Arnett B
    Biochemistry; 2000 Aug; 39(32):9917-27. PubMed ID: 10933811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA minor groove-alkylating cyclopropylpyrroloindole drugs adozelesin and bizelesin induce different DNA damage response pathways in human colon carcinoma HCT116 cells.
    Cao PR; McHugh MM; Melendy T; Beerman T
    Mol Cancer Ther; 2003 Jul; 2(7):651-9. PubMed ID: 12883038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assay.
    Hidalgo M; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Mar; 10(3):295-302. PubMed ID: 10327036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the structural role of the internal guanine-cytosine base pair in recognition of a seven-base-pair sequence cross-linked by bizelesin.
    Thompson AS; Fan JY; Sun D; Hansen M; Hurley LH
    Biochemistry; 1995 Sep; 34(35):11005-16. PubMed ID: 7669758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkylation of guanine and cytosine in DNA by bizelesin. Evidence for a covalent immobilization leading to a proximity-driven alkylation of normally unreactive bases by a (+)-CC-1065 cross-linking compound.
    Sun D; Park HJ; Hurley LH
    Chem Res Toxicol; 1993; 6(6):889-94. PubMed ID: 8117929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065.
    Walker DL; Reid JM; Ames MM
    Cancer Chemother Pharmacol; 1994; 34(4):317-22. PubMed ID: 8033298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of AT-specific DNA-interstrand crosslinks by bizelesin in genomic and simian virus 40 DNA.
    Woynarowski JM; Chapman WG; Napier C; Herzig MC
    Biochim Biophys Acta; 1999 Feb; 1444(2):201-17. PubMed ID: 10023060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the structural role of the linking moieties in the DNA binding of adozelesin.
    Cameron L; Thompson AS
    Biochemistry; 2000 May; 39(17):5004-12. PubMed ID: 10819964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bizelesin (U-77779), a bifunctional alkylating minor groove agent, on genomic and simian virus 40 DNA.
    Woynarowski JM; McHugh MM; Gawron LS; Beerman TA
    Biochemistry; 1995 Oct; 34(40):13042-50. PubMed ID: 7548063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence selectivity of DNA alkylation by adozelesin and carzelesin.
    Yoon JH; Lee CS
    Arch Pharm Res; 1998 Aug; 21(4):385-90. PubMed ID: 9875464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in sequence selective minor groove DNA effectors.
    Reddy BS; Sharma SK; Lown JW
    Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA interstrand cross-links induced by the cyclopropylpyrroloindole antitumor agent bizelesin are reversible upon exposure to alkali.
    Lee CS; Gibson NW
    Biochemistry; 1993 Sep; 32(35):9108-14. PubMed ID: 8369282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the antitumor cyclopropylpyrroloindole antibiotic CC-1065 cross-link DNA in tumor cells?
    Skladanowski A; Koba M; Konopa J
    Biochem Pharmacol; 2001 Jan; 61(1):67-72. PubMed ID: 11137711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of DNA alkylation sites induced by aziridinylbenzoquinones in human cells by ligation-mediated polymerase chain reaction.
    Lee CS; Pfeifer GP; Gibson NW
    Cancer Res; 1994 Apr; 54(7):1622-6. PubMed ID: 8137269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs.
    Woynarowski JM; Krugliak M; Ginsburg H
    Mol Biochem Parasitol; 2007 Jul; 154(1):70-81. PubMed ID: 17524501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation spectra induced by adozelesin in the supF gene of human XP-A fibroblasts.
    Lee SY; Pfeifer GP; Lee CS
    Arch Pharm Res; 2010 Apr; 33(4):633-6. PubMed ID: 20422374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genome factor in region-specific DNA damage: the DNA-reactive drug U-78779 prefers mixed A/T-G/C sequences at the nucleotide level but is region-specific for long pure AT islands at the genomic level.
    Herzig MC; Rodriguez KA; Trevino AV; Dziegielewski J; Arnett B; Hurley L; Woynarowski JM
    Biochemistry; 2002 Feb; 41(5):1545-55. PubMed ID: 11814348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bizelesin, a bifunctional cyclopropylpyrroloindole alkylating agent, inhibits simian virus 40 replication in trans by induction of an inhibitor.
    McHugh MM; Kuo SR; Walsh-O'Beirne MH; Liu JS; Melendy T; Beerman TA
    Biochemistry; 1999 Aug; 38(35):11508-15. PubMed ID: 10471303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin.
    Bhuyan BK; Smith KS; Kelly RC; Adams EG; Abraham I; Sampson KE
    Cancer Res; 1993 Mar; 53(6):1354-9. PubMed ID: 8443816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.